NYSE: MAIA - MAIA Biotechnology, Inc.

Yield per half year: +14.04%
Sector: Healthcare

Share chart MAIA Biotechnology, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

EBITDA -0.0069
Число акций ао 0.01699 млрд
P/BV 3.83
EV/EBITDA 0.2419
Цена ао 2.44
ISIN US5526411021
Сайт https://www.MAIABiotech.com
Валюта usd
IPO date 2022-07-28
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: -1.11% (2.71)
Change price per week: +1.13% (2.65)
Change price per month: -8.22% (2.92)
Change price per 3 month: -20.94% (3.39)
Change price per half year: +14.04% (2.35)
Change price per year: +20.78% (2.219)
Change price per year to date: +25.82% (2.13)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 30.83 1
P/E 0 0
EV/EBITDA -0.3718 0
Total: 2.63

Efficiency

Title Value Grade
ROA, % -261.31 0
ROE, % -4140.83 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 195.06 10
Yield EPS, % 144.22 10
Total: 8
More

Institutions Volume Share, %
Vanguard Group Inc 174159 0.87
Sabby Management, LLC 130510 0.65
Renaissance Technologies, LLC 111200 0.56
Bridgeway Capital Management, Inc. 75700 0.38
Centric Wealth Management 67198 0.34
Citadel Advisors Llc 57473 0.29
Geode Capital Management, LLC 44557 0.22
XTX Topco Ltd 23965 0.12
Naviter Wealth, LLC 22168 0.11
State Street Corporation 21300 0.11

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Micro-Cap ETF 0.00935 36.318555985322 1.54048



Head Job title Payment Year of birth
Dr. Vlad Vitoc M.B.A., M.D. Co-Founder, President, CEO & Chairman of the Board of Directors 529.82k 1970 (54 years)
Dr. Sergei M. Gryaznov Ph.D. Chief Scientific Officer 417.33k 1960 (64 years)
Mr. Jeffrey C. Himmelreich Head of Finance 213.17k 1975 (49 years)
Linda Moreira Company Secretary N/A

Address: United States, Chicago. IL, 444 West Lake Street - open in Google maps, open in Yandex maps
Website: https://www.MAIABiotech.com